1) Weiss N, Miller F, Cazaubon S, Couraud PO. The blood–brain barrier in brain homeostasis and neurological diseases. Biochim. Biophys. Acta, 1788:842-857, 2009.
2) Desai BS, Monahan AJ, Carvey PM, Hendey B. Blood–brain barrier pathology in Alzheimer's and Parkinson's disease: implications for drug therapy. Cell Transplant., 16:285-299, 2007.
3) Deo AK, Theil FP, Nicolas JM. Confounding parameters in preclinical assessment of blood–brain barrier permeation: an overview with emphasis on species differences and effect of disease states. Mol. Pharm., 10: 1581-1595, 2013.
4) Stanimirovic DB, Sandhu JK, Costain WJ. Emerging Technologies for Delivery of Biotherapeutics and Gene Therapy Across the Blood–Brain Barrier. BioDrugs, 32: 547-559, 2018.
5) Helms HC, Abbott NJ, Burek M, Cecchelli R, Couraud PO, Deli MA, Förster C, Galla HJ, Romero IA, Shusta EV, Stebbins MJ, Vandenhaute E, Weksler B, BrodinB. In vitro models of the blood–brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use. J. Cerebr. Blood F. Met., 36:862-890, 2016.
6) Lippmann ES, Al-Ahmad A, Palecek SP, Shusta EV. Modeling the blood–brain barrier using stem cell sources. Fluids Barriers CNS, 10:2, 2013.
7) Lippmann ES, Azarin SM, Kay JE, Nessler RA, Wilson HK, Al-Ahmad A. Derivation of blood–brain barrier endothelial cells from human pluripotent stem cells. Nat. Biotechnol., 30:783-791, 2012.
8) Lippmann ES, Al-Ahmad A, Azarin SM, Palecek SP, Shusta EV. A retinoic acid- enhanced, multicellular human blood–brain barrier model derived from stem cell sources. Sci. Rep., 4:4160, 2014.
9) Neal EH, Marinelli NA, Shi Y, McClatchey PM, Balotin KM, Gullett DR, Hagerla KA, Bowman AB, Ess KC, Wikswo JP, Lippmann ES. A simplified, fully defined differentiation scheme for producing blood–brain barrier endothelial cells from human iPSCs. Stem Cell Rep., 12:1380-1388, 2019.
10) Hollmann EK, Bailey AK, Potharazu AV, Neely MD, Bowman AB, Lippmann ES. Accelerated differentiation of human induced pluripotent stem cells to blood–brain barrier endothelial cells. Fluids Barriers CNS, 14:9, 2017.
11) Park TE, Mustafaoglu N, Herland A, Hasselkus R, Mannix R, FitzGerald EA, Prantil- Baun R, Watters A, Henry O, Benz M, Sanchez H, McCrea HJ, Goumnerova LC,Song HW, Palecek SP, Shusta E, Ingber DE. Hypoxia-enhanced Blood-Brain Barrier Chip recapitulates human barrier function and shuttling of drugs and antibodies. Nat. Commun., 10:2621, 2019.
12) Patel R and Alahmad AJ. Growth-factor reduced Matrigel source influences stem cell derived brain microvascular endothelial cell barrier properties. Fluids Barriers CNS, 13:6, 2016.
13) Appelt-Menzel A, Cubukova A, Günther K, Edenhofer F, Piontek J, Krause G, Stüber T, Walles H, Neuhaus W, Metzger M. Establishment of a human blood–brain barrier co-culture model mimicking the neurovascular unit using induced pluri- and multipotent stem cells. Stem Cell Rep., 8:894-906, 2017.
14) Kruegel J and Miosge N. Basement membrane components are key players in specialized extracellular matrices. Cell Mol. Life Sci., 67:2879-2895, 2010.
15) Yap L, Wang JW, Moreno-Moral A, Chong LY, Sun Y, Harmston N, Wang X, Chong SY, Öhman MK, Wei H, Bunte R, Gosh S, Cook S, Hovatta O, de Kleijn DPV, Petretto E, Tryggvason K. In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors. Cell rep., 26:3231-3245, 2019.
16) Baeten KM and Akassoglou K. Extracellular matrix and matrix receptors in blood– brain barrier formation and stroke. Dev. Neurobiol., 71:1018-1039, 2011.
17) Delsing L, Donnes P, Sanchez J, Clausen M, Voulgaris D, Falk A, Herland A, Brolén G, Zetterberg H, Hicks R, Synnergren J. Barrier properties and transcriptome expression in human iPSC-derived models of the blood–brain barrier. Stem Cells, 36:1816-1827, 2018.
18) Li H, Daculsi R, Grellier M, Bareille R, Bourget C, Remy M, Amedee J. The role of vascular actors in two dimensional dialogue of human bone marrow stromal cell and endothelial cell for inducing self-assembled network. PLoS One, 6:e16767, 2011.
19) Weksler BB, Subileau EA, Perriere N, Charneau P, Holloway K, Leveque M, Tricoire-Leignel H, Nicotra A, Bourdoulous S, Turowski P, Male DK, Roux F, Greenwood J, Romero IA, Couraud PO. Blood–brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J., 19:1872-1874, 2005.
20) Assmann JC, Müller K, Wenzel J, Walther T, Brands J, Thornton P, Allan SM, Schwaninger M. Isolation and cultivation of primary brain endothelial cells from adult mice. Bio Protoc., 7:e2294, 2017.
21) Saili KS, Zurlinden TJ, Schwab AJ, Silvin A, Baker NC, Hunter ES 3rd, Ginhoux F, Knudsen TB. Blood–brain barrier development: Systems modeling and predictive toxicology. Birth Defects Res., 109:1680-1710, 2017.
22) Tan JY, Sriram G, Rufaihah AJ, Neoh KG, Cao T. Efficient derivation of lateral plate and paraxial mesoderm subtypes from human embryonic stem cells through GSKi- mediated differentiation. Stem Cells Dev., 22:1893-1906, 2013.
23) Lian X, Bao X, Al-Ahmad A, Liu J, Wu Y, Dong W, Dunn KK, Shusta EV, Palecek SP. Efficient differentiation of human pluripotent stem cells to endothelial progenitors via small-molecule activation of WNT signaling. Stem Cell Rep., 3:804- 816, 2014.
24) Ikuno T, Masumoto H, Yamamizu K, Yoshioka M, Minakata K, Ikeda T, Sakata R, Yamashita JK. Efficient and robust differentiation of endothelial cells from human induced pluripotent stem cells via lineage control with VEGF and cyclic AMP. PLoS One, 12:e0173271, 2017.
25) Igreja C, Fragoso R, Caiado F, Clode N, Henriques A, Camargo L, Reis EM, Dias S. Detailed molecular characterization of cord blood-derived endothelial progenitors. Exp. Hematol., 36:193-203, 2008.
26) Takayama N, Nishikii H, Usui J, Tsukui H, Sawaguchi A, Hiroyama T, Eto K, Nakauchi H. Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors. Blood, 111:5298-5306, 2008.
27) 高山直也.ヒト ES 細胞・iPS 細胞から ES(iPS)-Sac を介する血液誘導法の確立. 第 8 回日本再生医療学会総会抄録集. 8 (supple):149, 2009.
28) Fujita A, Uchida N, Haro-Mora JJ, Winkler T, Tisdale J. β-globin-expressing definitive erythroid progenitor cells generated from embryonic and induced pluripotent stem cell-derived sacs. Stem Cells, 34:1541-1552, 2016.
29) Uchida N, Haro-Mora JJ, Fujita A, Lee DY, Winkler T, MM Hsieh, Tisdale JF. Efficient generation of β-globin-expressing erythroid cells using stromal cell-derived induced pluripotent stem cells from patients with sickle cell disease. Stem Cells, 35: 586-596, 2017.
30) Sriram G, Tan JY, Islam I, Rufaihah AJ, Cao T. Efficient differentiation of human embryonic stem cells to arterial and venous endothelial cells under feeder- and serum-free conditions. Stem Cell Res. Ther., 6:261, 2015.
31) Nguyen MT, Okina E, Chai X, Tan KH, Hovatta O, Ghosh S, Tryggvason K. Differentiation of human embryonic stem cells to endothelial progenitor cells on laminins in defined and xeno-free systems. Stem Cell Rep., 7:802-816, 2016.
32) Doura T, Kamiya M, Obata F, Yamaguchi Y, Hiyama TY, Matsuda T, Fukamizu A, Noda M, Miura M, Urano Y. Detection of LacZ-positive cells in living tissue with single-cell resolution. Angew. Chem., 55:9620-9624, 2016.
33) Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS., 16:284-287, 2012.
34) Ogami K, Richard P, Chen Y, Hoque M, Li W, Moresco JJ, Yates JR 3rd, Tian B, Manley JL. An Mtr4/ZFC3H1 complex facilitates turnover of unstable nuclear RNAs to prevent their cytoplasmic transport and global translational repression. Genes Dev., 31:1257-1271, 2017.
35) Katsuda T, Kawamata M, Hagiwara K, Takahashi RU, Yamamoto Y, Camargo FD, Ochiya T. Conversion of terminally committed hepatocytes to culturable bipotent progenitor cells with regenerative capacity. Cell Stem Cell, 20:41-55, 2017.
36) Joo HJ, Choi DK, Lim JS, Park JS, Lee SH, Song S, Shin JH, Lim DS, Kim I, Hwang KC, Koh GY. ROCK suppression promotes differentiation and expansion of endothelial cells from embryonic stem cell-derived Flk1+ mesodermal precursor cells. Blood, 120:2733-2744, 2012.
37) James D, Nam HS, Seandel M, Nolan D, Janovitz T, Tomishima M, Studer L, Lee G, Lyden D, Benezra R, Zaninovic N, Rosenwaks Z, Rabbany SY, Rafii S. Expansion and maintenance of human embryonic stem cell-derived endothelial cells by TGFβ inhibition is Id1 dependent. Nat. Biotechnol., 28:161-166, 2010.
38) Masckauchan TN, Shawber CJ, Funahashi Y, Li CM, Kitajewski J. Wnt/β-catenin signaling induces proliferation, survival and interleukin-8 in human endothelial cells. Angiogenesis, 8:43-51, 2005.
39) Hayashi T, Yano K, Matsui-Hirai H, Yokoo H, Hattori Y, Iguchi A. Nitric oxide and endothelial cellular senescence. Pharmacol. Ther., 120:333-339, 2008.
40) Llufrio EM, Wang L, Naser FJ, Patti GJ. Sorting cells alters their redox state and cellular metabolome. Redox Biol., 16:381-387, 2018.
41) Nguyen QH, Lukowski SW, Chiu HS, Senabouth A, Bruxner TJC, Christ AN, Palpant NJ, Powell JE. Single-cell RNA-seq of human induced pluripotent stem cells reveals cellular heterogeneity and cell state transitions between subpopulations. Genome Res., 28:1053-1066, 2018.
42) Ikuno T, Masumoto H, Yamamizu K, Yoshioka M, Minakata K, Ikeda T, Sakata R, Yamashita JK. Efficient and robust differentiation of endothelial cells from human induced pluripotent stem cells via lineage control with VEGF and cyclic AMP. PLoS One, 12:e0173271, 2017.
43) Cheng CC, Chang SJ, Chueh YN, Huang TS, Huang PH, Cheng SM, Tsai TN, Chen JW, Wang HW. Distinct angiogenesis roles and surface markers of early and late endothelial progenitor cells revealed by functional group analyses. BMC Genomics, 14:182, 2013.
44) Ormiston ML, Toshner MR, Kiskin FN, Huang CJZ, Groves E, Morrell NW, RanaAA. Generation and culture of blood outgrowth endothelial cells from human peripheral blood. J. Vis. Exp., 106:e53384, 2015.
45) Smadja DM, Bièche I, Helley D, Laurendeau I, Simonin G, Muller L, Aiach M, Gaussem P. Increased VEGFR2 expression during human late endothelial progenitor cells expansion enhances in vitro angiogenesis with up-regulation of integrin α6. J. Cell Mol. Med., 11:1149-1161, 2007.
46) Harding A, Cortez-Toledo E, Magner NL, Beegle JR, Coleal-Bergum DP, Hao D, Wang A, Nolta JA, Zhou P. Highly efficient differentiation of endothelial cells from pluripotent stem cells requires the MAPK and the PI3K pathways. Stem Cells, 4:909- 919, 2017.
47) Okae H, Toh H, Sato T, Hiura H, Takahashi S, Shirane K, Kabayama Y, Suyama M, Sasaki H, Arima T. Derivation of human trophoblast stem cells. Cell Stem Cell, 1:50- 63, 2018.
48) Zhang RR, Koido M, Tadokoro T, Ouchi R, Matsuno T, Ueno Y, Sekine K, Takebe T, Taniguchi H. Human iPSC-derived posterior gut progenitors are expandable and capable of forming gut and liver organoids. Stem Cell Rep., 10:780-793, 2018.
49) Xie X, Guo P, Yu H, Wang Y, Chen G. Ribosomal proteins: insight into molecular roles and functions in hepatocellular carcinoma. Oncogene, 37:277-285, 2018.
50) Shahbazian D, Parsyan A, Petroulakis E, Topisirovic I, Martineau Y, Gibbs BF, Svitkin Y, Sonenberg N. Control of cell survival and proliferation by mammalian eukaryotic initiation factor 4B. Mol. Cell Biol., 30:1478-1485, 2010.
51) Polymenis M, Aramayo R. Translate to divide: сontrol of the cell cycle by protein synthesis. Microb. Cell., 2:94-104, 2015.
52) Kuwahara K., Saito Y, Nakagawa O, Kishimoto I, Harada M, Ogawa E, Miyamoto Y, Hamanaka I, Kajiyama N, Takahashi N, Izumi T, Kawakami R, Tamura N, Ogawa Y, Nakao K. The effects of the selective ROCK inhibitor, Y27632, on ET-1-induced hypertrophic response in neonatal rat cardiac myocytes-possible involvement of Rho/ROCK pathway in cardiac muscle cell hypertrophy. FEBS Lett., 452:314-318, 1999.
53) Nguyen-McCarty M, Klein PS. Autophagy is a signature of a signaling network that maintains hematopoietic stem cells. PLoS One, 12:e0177054, 2017.
論文の公開元へ
